2,3,7,8-tetrachlorodibenzo-p-dioxin decrease expression of aryl hydrocarbon receptor in peripheral lymphocyte of β-thalassemia major patients


1 Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan; Department of Stem Cell Biology, Stem Cell Technology Research Center Tarbiat Modares University, Tehran, Iran

2 Department of Hematology, Tarbiat Modares University, Tehran, Iran

3 Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Immunology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran


Background: β-thalassemia major is a hereditary disease with inefficient erythropoiesis. Level of inflammatory cytokine is elevated in these patients. In this study, we investigate the effect of aryl hydrocarbon receptor (AhR) ligand, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), on the expression of inflammatory mediators in β-thalassemia major patient's lymphocytes.
Materials and Methods: Peripheral blood mononuclear cells of patients and healthy participants was isolated and cultured in favor of lymphocytes increment. Based on the treatment, we divided the cell into four groups. The orders of group's treatments were no treatment, tumor necrosis factor-α (TNF-α) treatment, TNF-α and TCDD treatment, TCDD treatment in Group 1–4, respectively. After cell culture, we extracted the cells RNA and converted them to cDNA. Real-time polymerase chain reaction was performed to assessment relative expression of caspase-1, NLRP3, and AhR. We compared all patient groups with equal healthy (control) groups.
Results: Results showed that expression of caspase-1 in patients (Groups 1 and 2) was significantly lower than healthy individuals (P < 0.05). Although, no significant difference was found (Groups 1, 2, and control) in AhR gene expression (P > 0.05). Expression of AhR in other groups of patients (3 and 4) was significantly lower than control groups (P < 0.05). Expression of caspase-1 in Group 4 was significantly larger than the control group (P < 0.001).
Conclusions: We show here that chronic inflammation decrease caspase-1 expression and exposure of human lymphocytes to TCDD promote caspase-1 expression. Furthermore, activation of AhR with TCDD decreases AhR expression in lymphocytes of β-thalassemia major disease.


Ribeil JA, Arlet JB, Dussiot M, Moura IC, Courtois G, Hermine O. Ineffective erythropoiesis in ß -thalassemia. ScientificWorldJournal 2013;2013:394295.  Back to cited text no. 1
Mahmoud SM, Sahar B. Aziz Evaluation of certain inflammatory markers in transfusion dependent β-thalassemic patients. Tikrit J Pharm Sci 2013;9:6-7  Back to cited text no. 2
Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005;353:1135-46.  Back to cited text no. 3
Cunningham-Rundles S, Giardina PJ, Grady RW, Califano C, McKenzie P, De Sousa M. Effect of transfusional iron overload on immune response. J Infect Dis 2000;182 Suppl 1:S115-21.  Back to cited text no. 4
Pieracci FM, Barie PS. Iron and the risk of infection. Surg Infect (Larchmt) 2005;6 Suppl 1:S41-6.  Back to cited text no. 5
Wang SC, Lin KH, Chern JP, Lu MY, Jou ST, Lin DT, et al. Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin Infect Dis 2003;37:984-8.  Back to cited text no. 6
Kuppusamy UR, Tan JA. Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients. West Indian Med J 2011;60:3-8.  Back to cited text no. 7
Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, Morini E, et al. The "lively" cytokines network in beta-thalassemia major-related osteoporosis. Bone 2007;40:1588-94.  Back to cited text no. 8
Álvarez S, Muñoz-Fernández MÁ. TNF-Α may mediate inflammasome activation in the absence of bacterial infection in more than one way. PLoS One 2013;8:e71477.  Back to cited text no. 9
Chow MT, Duret H, Andrews DM, Faveeuw C, Möller A, Smyth MJ, et al. Type I NKT-cell-mediated TNF-a is a positive regulator of NLRP3 inflammasome priming. Eur J Immunol 2014;44:2111-20.  Back to cited text no. 10
Di Meglio P, Duarte JH, Ahlfors H, Owens ND, Li Y, Villanova F, et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 2014;40:989-1001.  Back to cited text no. 11
Ikuta T, Kobayashi Y, Kitazawa M, Shiizaki K, Itano N, Noda T, et al. ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice. Carcinogenesis 2013;34:1620-7.  Back to cited text no. 12
Beamer CA, Seaver BP, Shepherd DM. Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis. Toxicol Sci 2012;126:554-68.  Back to cited text no. 13
Vogel CF, Khan EM, Leung PS, Gershwin ME, Chang WL, Wu D, et al. Cross-talk between aryl hydrocarbon receptor and the inflammatory response: A role for nuclear factor-kB. J Biol Chem 2014;289:1866-75.  Back to cited text no. 14
Gupta S. A road to ruins: An insight into immunosenescence. Basic Biol Clin Impact Immunosenescence 2003;13:173.  Back to cited text no. 15
Hanieh H. Toward understanding the role of aryl hydrocarbon receptor in the immune system: Current progress and future trends. Biomed Res Int 2014;2014:520763.  Back to cited text no. 16
Nguyen NT, Hanieh H, Nakahama T, Kishimoto T. The roles of aryl hydrocarbon receptor in immune responses. Int Immunol 2013;25:335-43.  Back to cited text no. 17
Kimura A, Abe H, Tsuruta S, Chiba S, Fujii-Kuriyama Y, Sekiya T, et al. Aryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production. Int Immunol 2014;26:209-20.  Back to cited text no. 18
Zhu C, Xie Q, Zhao B. The role of AhR in autoimmune regulation and its potential as a therapeutic target against CD4 T cell mediated inflammatory disorder. Int J Mol Sci 2014;15:10116-35.  Back to cited text no. 19
Vogel CF, Sciullo E, Matsumura F. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochem Biophys Res Commun 2007;363:722-6.  Back to cited text no. 20
Champion S, Sauzet C, Bremond P, Benbrahim K, Abraldes J, Seree E, et al. Activation of the NF kB pathway enhances AhR expression in intestinal caco-2 cells. ISRN Toxicol 2013;2013:792452.  Back to cited text no. 21
Tian Y, Ke S, Denison MS, Rabson AB, Gallo MA. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 1999;274:510-5.  Back to cited text no. 22